1. Home
  2. HRMY vs RNST Comparison

HRMY vs RNST Comparison

Compare HRMY & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$37.78

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

RNST

Renasant Corporation

HOLD

Current Price

$36.05

Market Cap

3.3B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HRMY
RNST
Founded
2017
1904
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
3.3B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
HRMY
RNST
Price
$37.78
$36.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
6
Target Price
$51.33
$43.17
AVG Volume (30 Days)
695.1K
540.9K
Earning Date
11-04-2025
01-27-2026
Dividend Yield
N/A
2.54%
EPS Growth
50.44
N/A
EPS
3.17
1.84
Revenue
$825,944,000.00
$775,309,000.00
Revenue This Year
$23.11
$43.37
Revenue Next Year
$16.15
$13.13
P/E Ratio
$12.04
$19.70
Revenue Growth
21.13
13.04
52 Week Low
$25.52
$26.97
52 Week High
$40.93
$40.40

Technical Indicators

Market Signals
Indicator
HRMY
RNST
Relative Strength Index (RSI) 54.65 47.75
Support Level $37.12 $36.84
Resistance Level $39.60 $36.33
Average True Range (ATR) 1.15 0.65
MACD -0.38 -0.15
Stochastic Oscillator 17.33 6.70

Price Performance

Historical Comparison
HRMY
RNST

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: